Gregory A. Otterson
- Oncology top 0.2%
- Lung Cancer Research Studies 50
- Cancer Immunotherapy and Biomarkers 43
- Colorectal Cancer Treatments and Studies 31
- Cancer-related Molecular Pathways 27
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 27
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 93
- Lung Cancer Diagnosis and Treatment 23
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 21
- Immunology top 5%
- Co-authors
- Frederic J. KayeWei‐Guo ZhuMiguel A. Villalona‐CaleroErin M. BertinoAmy CoxonRobert A. KratzkeSamir N. KhleifChristoph Plass
- Journals
- Journal of Clinical Oncology (44 papers)Journal of Thoracic Oncology (27 papers)Lung Cancer (11 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
Gregory A. Otterson
235 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 5.0k
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 3.4k
- Molecular Biology 5.1k
- Immunology 692
Countries citing papers authored by Gregory A. Otterson
This map shows the geographic impact of Gregory A. Otterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Otterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Otterson more than expected).
Fields of papers citing papers by Gregory A. Otterson
This network shows the impact of papers produced by Gregory A. Otterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Otterson. The network helps show where Gregory A. Otterson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gregory A. Otterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 1 | |
| 4 | Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Studybreakdown → | 2021 | 165 |
| 5 | 2019 | 82 | |
| 6 | 2018 | 17 | |
| 7 | 2018 | 24 | |
| 8 | 2017 | 24 | |
| 9 | 2016 | 22 | |
| 10 | 2016 | 40 | |
| 11 | 2015 | 11 | |
| 12 | 2012 | 3 | |
| 13 | 2011 | 125 | |
| 14 | 2010 | 11 | |
| 15 | Abstract #LB-131: Biomarker evaluation in the Phase III, placebo (P)-controlled, randomized BeTa trial of bevacizumab (B) and erlotinib (E) for patients (pts) with advanced non-small cell lung cancer (NSCLC) after failure of standard 1st-line chemotherapy: correlation with treatment outcomes | 2009 | 1 |
| 16 | 2008 | 227 | |
| 17 | 2007 | 1 | |
| 18 | 2006 | 123 | |
| 19 | 2004 | 29 | |
| 20 | 1995 | 80 |
About Gregory A. Otterson
Gregory A. Otterson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 240 papers that have together received 10.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (93 papers), Lung Cancer Research Studies (50 papers), Cancer Immunotherapy and Biomarkers (43 papers), Colorectal Cancer Treatments and Studies (31 papers), Cancer Genomics and Diagnostics (27 papers), Cancer-related Molecular Pathways (27 papers), Lung Cancer Diagnosis and Treatment (23 papers) and Epigenetics and DNA Methylation (21 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.8k citations) and Pulmonary and Respiratory Medicine (3.4k citations). Gregory A. Otterson has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Frederic J. Kaye, Wei‐Guo Zhu, Miguel A. Villalona‐Calero, Erin M. Bertino, Amy Coxon, Robert A. Kratzke, Samir N. Khleif, Christoph Plass, Wenrui Duan and Dwight H. Owen. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, Annals of Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.